Detalles de la búsqueda
1.
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma.
J Hepatol
; 77(3): 683-694, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430299
2.
Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD).
Am J Med Genet A
; 164A(10): 2592-600, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25131847
3.
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.
Liver Cancer
; 12(1): 7-18, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36872922
4.
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole blood.
Immunother Adv
; 3(1): ltad015, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37636242
5.
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?
Asia Pac J Clin Oncol
; 19(3): 312-319, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950298
6.
CD38 marks the exhausted CD8+ tissue-resident memory T cells in hepatocellular carcinoma.
Front Immunol
; 14: 1182016, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37377962
7.
Immunohistochemical scoring of LAG-3 in conjunction with CD8 in the tumor microenvironment predicts response to immunotherapy in hepatocellular carcinoma.
Front Immunol
; 14: 1150985, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37342338
8.
Multimodal molecular landscape of response to Y90-resin microsphere radioembolization followed by nivolumab for advanced hepatocellular carcinoma.
J Immunother Cancer
; 11(8)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37586766
9.
Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma.
Liver Cancer
; 11(1): 9-21, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35222504
10.
Systemic Treatment of Advanced Unresectable Hepatocellular Carcinoma after First-Line Therapy: Expert Recommendations from Hong Kong, Singapore, and Taiwan.
Liver Cancer
; 11(5): 426-439, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36158587
11.
Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma.
Acta Oncol
; 55(4): 519-20, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26754959
12.
Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center.
Asia Pac J Clin Oncol
; 17(5): e249-e261, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32875742
13.
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.
Liver Cancer
; 10(2): 107-114, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977087
14.
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
Lancet Gastroenterol Hepatol
; 6(12): 1025-1035, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34695377
15.
Resected pancreatic adenocarcinoma: An Asian institution's experience.
Cancer Rep (Hoboken)
; 4(5): e1393, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33939335
16.
Family History of Eating Disorder and the Broad Autism Phenotype in Autism.
Autism Res
; 13(9): 1573-1581, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888262
17.
Human epidermal growth factor receptor 2 positive rates in invasive lobular breast carcinoma: The Singapore experience.
World J Clin Oncol
; 11(5): 283-293, 2020 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728531
18.
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma.
J Immunother Cancer
; 8(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32847986
19.
Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial.
Front Neurol
; 11: 604688, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33424755
20.
Hyperprogressive disease in hepatocellular carcinoma with immune checkpoint inhibitor use: a case series.
Immunotherapy
; 11(3): 167-175, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30730278